ADHC .15 Price Target by Goldman Small Cap Research...
This is good news for ADHC of being given a .15 Price Target by Goldman Small Cap Research and with the launching of their new website of CBD Products. I truly believe that they gave ADHC this price target of .15 per share not because of what is known right now, but because of what I believe is going to be revealed as known that's coming in the future. Just think, Goldman Small Cap Research gave a price target of actually .25 per share for PURA and it actually hit that price target. This was mentioned in both PRs for PURA and ADHC:
https://ih.advfn.com/stock-market/USOTC/american-diversified-holdings-ADHC/stock-news/78909260/www-thecbdklub-com-open-for-business Recently, Goldman Small Cap Research issued a research report on the Company. The report includes a 'speculative-buy' rating with a target price-per-share of $0.15 (fifteen cents). The report provides an in-depth overview and analysis of ADHC's two operating divisions, www.AuracisMigraine.com (Migraine Bio-Device) and www.TheCBDKlub.com (Cannabis E-commerce Platform). To view the report, along with disclosures and disclaimers, visit www.GoldmanResearch.com. Goldman Small Cap Research recently wrote a report on another cannabis company PURATION (PURA) and the stock met Goldman's price target of .26 per share.